The Northern Illinois University College of Business and MATTER, a Chicago-based educational nonprofit, announced on December 4, 2018, the launch of a partnered initiative to provide early career real-world exposure to NIU students. Jeff Aronin, Founder and co-chairman of MATTER and NIU alumnus, expressed pride and support of this effort.
As an entrepreneur himself, and as an active investor in health care startups, Aronin has extensive experience with the challenges faced by many health care companies. Jeff Aronin is also the CEO of the Chicago-based Paragon Biosciences. His company builds bioscience companies seeking to improve the lives of patients who suffer from severe medical conditions.
About Northern Illinois University College of Business
NIU College of Business is a nationally ranked business school, cited by U.S. News & World Report as among the nation’s best for 2019, the 32nd consecutive year in which it has received this recognition. NIU has an outstanding reputation for preparing its business students for the realities and challenges of both corporate careers and entrepreneurial endeavors.
About Jeff Aronin and MATTER
Jeff Aronin graduated from NIU in 1989 with a B.S. in Marketing and holds an M.B.A. from DePaul University. He has focused his entire professional career on leading companies in the health care and life sciences fields. Before he started Paragon Biosciences LLC., Aronin founded and served as the CEO of two successful biopharmaceutical companies. In 2016, he was awarded a prestigious Medallion for Entrepreneurship by the Beta Gamma Sigma International Business Honor Society, one of only four recipients to receive the honor that year. Aronin also serves as a guest lecturer on entrepreneurship at the University of Chicago Booth School of Business and Northwestern University’s Kellogg School of Management.
MATTER is a nonprofit and no-equity entity founded by Jeff Aronin in February 2015. Its mission is to serve as an “incubator” for early-stage business concepts in the health care space and related fields. Headquartered in a state-of-the-art facility in the Chicago Merchandise Mart, the organization sponsors lectures and courses to equip entrepreneurs and innovators to take on the challenges of a demanding and complex business and regulatory environment. A notable element of the MATTER educational mission is the pairing of start-up entities with mentors and research resources drawn from among other MATTER members.
How NIU Students Stand to Benefit
The NIU College of Business curriculum includes an Experiential Learning Center (ELC) for both undergraduate and graduate students. This is a 16-week course that brings students together with experienced business executives. Under the newly announced initiative with MATTER, ELC undergraduate students will be assigned to work with two MATTER startup companies throughout the program, with mentorship and guidance provided by NIU faculty. Graduate students in the college’s executive MBA program will have an opportunity for an immersive consultation with three MATTER startup companies, again under the guidance of NIU faculty. Both BA and MBA programs will culminate with the student preparing a comprehensive business plan for the assigned MATTER member company, thus underscoring the focus of the ELC program, combining academic insight with hands-on business experience.
A Win-Win Partnership
The partnership between NIU and MATTER defines an innovative collaboration between a public university and private sector enterprise. It allows NIU students to gain important early career experience, facilitates the sharing of NIU’s collective research and understanding in an open and mutually supportive setting, and encourages and supports the growth and maturation of the MATTER member companies. In no small measure, the partnership reflects Jeff Aronin’s business philosophy: find the best new idea, surround it with the best advice, and create a new business reality, while improving the quality of patients’ lives.
More about NIU, MATTER, and Jeff Aronin at https://www.dailyforexreport.com/jeff-aronins-company-paragon-biosciences-became-investment-incubator/